Weiss Multi-Strategy Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,073	Closed	-$202K	–	733
2021 Q2	$202K	Buy	+5,073	New	+$199K	﹤0.01%	623
2019 Q4	–	Sell	-10,000	Closed	-$599K	–	661
2019 Q3	$599K	Hold	10,000	–	–	0.01%	480
2019 Q2	$643K	Sell	10,000 -5,000	-33%	-$353K	0.02%	409
2019 Q1	$1.22M	Sell	15,000 -5,000	-25%	-$323K	0.03%	372
2018 Q4	$1.08M	Sell	20,000 -5,116	-20%	-$261K	0.05%	287
2018 Q3	$1.29M	Buy	25,116 +116	+0.5%	+$5.45K	0.03%	375
2018 Q2	$1.04M	Hold	25,000	–	–	0.02%	437
2018 Q1	$1.1M	Buy	25,000 +5,000	+25%	+$254K	0.03%	406
2017 Q4	$1.01M	Buy	+20,000	New	+$1.1M	0.03%	437
2017 Q1	–	Sell	-10,000	Closed	-$449K	–	587
2016 Q4	$478K	Hold	10,000	–	–	0.02%	331
2016 Q3	$366K	Buy	+10,000	New	+$313K	0.02%	362
2016 Q2	–	Sell	-5,000	Closed	-$203K	–	454
2016 Q1	$203K	Buy	+5,000	New	+$203K	0.01%	427
2014 Q2	–	Sell	-8,800	Closed	-$277K	–	820
2014 Q1	$380K	Sell	8,800 -1,410	-14%	-$68.3K	0.01%	773
2013 Q4	$407K	Buy	+10,210	New	+$364K	0.01%	675

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Weiss Multi-Strategy Advisers's IONS Position: Q3 2021 in Review

Weiss Multi-Strategy Advisers sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 5,073 shares — an estimated $202K sold.

Weiss Multi-Strategy Advisers first reported a position in IONS in Q4 2013 and held it in 14 quarters. The position peaked at $1.29M in Q3 2018. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

Weiss Multi-Strategy Advisers reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 5,073 Ionis Pharmaceuticals shares in Q3 2021, an estimated $202K.
Weiss Multi-Strategy Advisers first reported a position in Ionis Pharmaceuticals in Q4 2013 and held it in 14 quarters.
Weiss Multi-Strategy Advisers's Ionis Pharmaceuticals position peaked at $1.29M in Q3 2018.
324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.